925: Non-reportable cell-free DNA: patient preferences, utility of repeat draw, and outcomes

MLA

Neil S. Silverman, et al. “925: Non-Reportable Cell-Free DNA: Patient Preferences, Utility of Repeat Draw, and Outcomes.” American Journal of Obstetrics and Gynecology, vol. 220, Jan. 2019, p. S597. EBSCOhost, https://doi.org/10.1016/j.ajog.2018.11.949.

APA

Neil S. Silverman, Ilina Datkhaeva, Christina S. Han, Gabriela Dellapiana, Yalda Afshar, Thalia Wong, & Lawrence D. Platt. (2019). 925: Non-reportable cell-free DNA: patient preferences, utility of repeat draw, and outcomes. American Journal of Obstetrics and Gynecology, 220, S597. https://doi.org/10.1016/j.ajog.2018.11.949

Chicago

Neil S. Silverman, Ilina Datkhaeva, Christina S. Han, Gabriela Dellapiana, Yalda Afshar, Thalia Wong, and Lawrence D. Platt. 2019. “925: Non-Reportable Cell-Free DNA: Patient Preferences, Utility of Repeat Draw, and Outcomes.” American Journal of Obstetrics and Gynecology 220 (January): S597. doi:10.1016/j.ajog.2018.11.949.